Developing an effective therapeutic by delivery of synthetic microRNA-520e in lung cancer treatment

Biomedicine and Pharmacotherapy

Volumn 69, Issue , 2015, Pages 249-254

  Ma, Dedong ^a   Lu, Hongxiu ^b   Qu, Yiqing ^a   Fu, Weijiang ^a   Ma, Zhe ^a  

^a SHANDONG UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Lung cancer treatment; MicroRNA 520e; Systematic delivery

Indexed keywords

CASPASE 3; LIVER ENZYME; MICRORNA; MICRORNA 520E; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; CYTOKINE; MIRN520 MICRORNA, HUMAN;

ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SYNTHESIS; EXPERIMENTAL NEOPLASM; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LOCAL THERAPY; LUNG CANCER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC THERAPY; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; BLOOD; CARCINOMA, NON-SMALL-CELL LUNG; DOWN REGULATION; DRUG SCREENING; GENE TRANSFER; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG NEOPLASMS; METABOLISM; NONOBESE DIABETIC MOUSE; PATHOLOGY; SCID MOUSE; TUMOR CELL LINE;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOKINES; DOWN-REGULATION; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; INFLAMMATION; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MICE, INBRED NOD; MICE, SCID; MICRORNAS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84922257722     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2014.12.009     Document Type: Article

References (29)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
3. Fabbri M. miRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn 2010, 10:435-444.
4. Baranwal S., Alahari S.K. miRNA control of tumor cell invasion and metastasis. Int J Cancer 2010, 126:1283-1290.
5. Wang R., Wang Z.X., Yang J.S., Pan X., De W., Chen L.B. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 2011, 30:2644-2658.
6. Bian H.B., Pan X., Yang J.S., Wang Z.X., De W. Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). J Exp Clin Cancer Res 2011, 30:20.
7. Su J., Wang Q., Liu Y., Zhong M. miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3. Mol Cell Biochem 2014, 392:289-296.
8. Fortunato O., Boeri M., Verri C., Moro M., Sozzi G. Therapeutic use of microRNAs in lung cancer. Biomed Res Int 2014, 2014:756975.
9. Weidhaas J.B., Babar I., Nallur S.M., Trang P., Roush S., Boehm M., et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007, 67:11111-11116.
10. Qi L., Bart J., Tan L.P., Platteel I., Sluis T., Huitema S., et al. Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer 2009, 9:163.
11. Adams B.D., Kasinski A.L., Slack F.J. Aberrant regulation and function of microRNAs in cancer. Curr Biol 2014, 24:R762-R776.
12. Ishiguro H., Kimura M., Takeyama H. Role of microRNAs in gastric cancer. World J Gastroenterol 2014, 20:5694-5699.
13. Guttilla I.K., White B.A. Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009, 284:23204-23216.
14. Yu S., Lu Z., Liu C., Meng Y., Ma Y., Zhao W., et al. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. Cancer Res 2010, 70:6015-6025.
15. Menghini R., Casagrande V., Cardellini M., Martelli E., Terrinoni A., Amati F., et al. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009, 120:1524-1532.
16. Kato M., Putta S., Wang M., Yuan H., Lanting L., Nair I., et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 2009, 11:881-889.
17. Zhang Y., Liu D., Chen X., Li J., Li L., Bian Z., et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010, 39:133-144.
18. Zhang S., Shan C., Kong G., Du Y., Ye L., Zhang X. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-kappaB-inducing kinase (NIK). Oncogene 2012, 31:3607-3620.
19. Dykxhoorn D.M. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res 2010, 70:6401-6406.
20. Hummel R., Hussey D.J., Haier J., MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types. Eur J Cancer 2010, 46:298-311.
21. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
22. Check Hayden E. Cancer complexity slows quest for cure. Nature 2008, 455:148.
23. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321:1801-1806.
24. Esquela-Kerscher A., Trang P., Wiggins J.F., Patrawala L., Cheng A., Ford L., et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008, 7:759-764.
25. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
26. Takeshita F., Patrawala L., Osaki M., Takahashi R.U., Yamamoto Y., Kosaka N., et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther 2010, 18:181-187.
27. Wiggins J.F., Ruffino L., Kelnar K., Omotola M., Patrawala L., Brown D., et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 2010, 70:5923-5930.
28. Li Q., Wang G., Shan J.L., Yang Z.X., Wang H.Z., Feng J., et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol 2010, 25:164-171.
29. Cui W., Zhang Y., Hu N., Shan C., Zhang S., Zhang W., et al. miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'-UTR of CD46. Cancer Biol Ther 2010, 10:232-241.